Medical Foods for Inborn Errors of Metabolism: History, Current Status, and Critical Need
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Successful intervention for inborn errors of metabolism (IEMs) is a triumph of modern medicine. For many of these conditions, medical foods are the cornerstone of therapy and the only effective interventions preventing disability or death. Medical foods are designed for patients with limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foods or nutrients, whereby dietary management cannot be achieved by modification of the normal diet alone. In the United States today, access to medical foods is not ensured for many individuals who are affected despite their proven efficacy in the treatment of IEMs, their universal use as the mainstay of IEM management, the endorsement of their use by professional medical organizations, and the obvious desire of families for effective care. Medical foods are not sufficiently covered by many health insurance plans in the United States and, without insurance coverage, many families cannot afford their high cost. In this review, we outline the history of medical foods, define their medical necessity, discuss the barriers to access and reimbursement resulting from the regulatory status of medical foods, and summarize previous efforts to improve access. The Advisory Committee on Heritable Disorders in Newborns and Children asserts that it is time to provide stable and affordable access to the effective management required for optimal outcomes through the life span of patients affected with IEMs. Medical foods as defined by the US Food and Drug Administration should be covered as required medical benefits for persons of all ages diagnosed with an IEM.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Medical Foods for Inborn Errors of Metabolism: History, Current Status, and Critical Need
- Date Crossref
- 01/03/2020
- Éditeur
- American Academy of Pediatrics (AAP)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Minnesota Department of Pediatrics pays non établi dans la noticeUniversité ou école supérieure
-
University of Maryland Department of Pediatrics pays non établi dans la noticeUniversité ou école supérieure
-
National Institutes of Health Office of Dietary Supplements pays non établi dans la noticeOrganisme public
-
Office of Dietary Supplements pays non établi dans la noticeOrganisme public
-
Health Resources and Services Administration pays non établi dans la noticeOrganisme public
-
Louisiana State University in Shreveport Department of Pediatrics pays non établi dans la noticeUniversité ou école supérieure
-
National Phenylketonuria Alliance Inc pays non établi dans la noticeEntreprise
-
Follow-up and Treatment Workgroup pays non établi dans la noticeInstitution
-
Independent Doctors pays non établi dans la noticeInstitution
-
Advisory Committee on Heritable Disorders in Newborns and Children pays non établi dans la noticeInstitution
Department of Pediatrics — University of Minnesota, Department of Pediatrics — University of Maryland et Office of Dietary Supplements — National Institutes of Health, avec 7 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.